NASDAQ:CGIX - Cancer Genetics News Headlines

Sign in or create an account to add this stock to your watchlist.
$0.2830 -0.03 (-9.58 %)
(As of 01/20/2019 09:51 AM ET)
Previous Close$0.2830
Today's Range$0.28 - $0.3189
52-Week Range$0.20 - $2.20
Volume2.51 million shs
Average Volume1.99 million shs
Market Capitalization$7.85 million
P/E Ratio-0.36
Dividend YieldN/A
Beta0.96

Headlines

Cancer Genetics (NASDAQ CGIX) News Headlines

Source:
DateHeadline
Cancer Genetics +16% on loan forbearance dealCancer Genetics +16% on loan forbearance deal
seekingalpha.com - January 17 at 8:14 AM
Cancer Genetics Inc (CGIX) CEO John A. Roberts Acquires 100,000 SharesCancer Genetics Inc (CGIX) CEO John A. Roberts Acquires 100,000 Shares
www.americanbankingnews.com - January 16 at 7:44 PM
Insider Buying: Cancer Genetics Inc (CGIX) Director Buys 1,000,000 Shares of StockInsider Buying: Cancer Genetics Inc (CGIX) Director Buys 1,000,000 Shares of Stock
www.americanbankingnews.com - January 16 at 7:33 PM
Cancer Genetics, Inc. Announces Closing of Public Offering of Common StockCancer Genetics, Inc. Announces Closing of Public Offering of Common Stock
finance.yahoo.com - January 14 at 6:11 PM
Head to Head Review: Guardant Health (GH) & Cancer Genetics (CGIX)Head to Head Review: Guardant Health (GH) & Cancer Genetics (CGIX)
www.americanbankingnews.com - January 10 at 7:31 PM
Cancer Genetics down 28% on pricing equity offeringCancer Genetics down 28% on pricing equity offering
seekingalpha.com - January 10 at 8:17 AM
Cancer Genetics, Inc. Announces Pricing of Public Offering of Common StockCancer Genetics, Inc. Announces Pricing of Public Offering of Common Stock
finance.yahoo.com - January 10 at 8:16 AM
Cancer Genetics readies stock offering; shares down 6% after hoursCancer Genetics readies stock offering; shares down 6% after hours
seekingalpha.com - January 9 at 7:05 PM
Cancer Genetics, Inc. Announces Proposed Public Offering of Common StockCancer Genetics, Inc. Announces Proposed Public Offering of Common Stock
finance.yahoo.com - January 9 at 7:05 PM
CBA Florida (CBAI) & Cancer Genetics (CGIX) Critical ComparisonCBA Florida (CBAI) & Cancer Genetics (CGIX) Critical Comparison
www.americanbankingnews.com - January 9 at 3:06 PM
Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma ServicesCancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
finance.yahoo.com - January 9 at 8:23 AM
Cancer Genetics (CGIX) Terminates Proposed Merger with NovellusDxCancer Genetics (CGIX) Terminates Proposed Merger with NovellusDx
www.streetinsider.com - December 17 at 5:47 PM
Cancer Genetics Terminates Proposed Merger with NovellusDxCancer Genetics Terminates Proposed Merger with NovellusDx
finance.yahoo.com - December 17 at 8:12 AM
Todays Research Reports on Trending Tickers: Adial Pharmaceuticals and Cancer GeneticsToday's Research Reports on Trending Tickers: Adial Pharmaceuticals and Cancer Genetics
finance.yahoo.com - December 14 at 8:15 AM
Cancer Genetics (CGIX) Reports Q3 Loss, Lags Revenue EstimatesCancer Genetics (CGIX) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - November 20 at 8:14 AM
Cancer Genetics: 3Q Earnings SnapshotCancer Genetics: 3Q Earnings Snapshot
finance.yahoo.com - November 19 at 5:25 PM
Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business UpdatesCancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
finance.yahoo.com - November 19 at 5:25 PM
Form 425 CANCER GENETICS, INC Filed by: CANCER GENETICS, INCForm 425 CANCER GENETICS, INC Filed by: CANCER GENETICS, INC
www.streetinsider.com - November 16 at 6:01 PM
Cancer Genetics (CGIX) Appoints Glenn Miles as Chief Financial OfficerCancer Genetics (CGIX) Appoints Glenn Miles as Chief Financial Officer
www.streetinsider.com - November 15 at 8:15 AM
Cancer Genetics Appoints Glenn Miles as Chief Financial OfficerCancer Genetics Appoints Glenn Miles as Chief Financial Officer
finance.yahoo.com - November 14 at 5:24 PM
Myriad Presents Two New Studies at the Western Section of the American Urological AssociationMyriad Presents Two New Studies at the Western Section of the American Urological Association
www.nasdaq.com - November 2 at 8:10 AM
Will Cancer Genetics (CGIX) Report Negative Earnings Next Week? What You Should KnowWill Cancer Genetics (CGIX) Report Negative Earnings Next Week? What You Should Know
finance.yahoo.com - November 1 at 6:10 PM
Cancer Genetics Issues Letter to ShareholdersCancer Genetics Issues Letter to Shareholders
finance.yahoo.com - October 16 at 8:18 AM
Cancer Genetics up 16% on collaborating with Cellaria for precision medicine toolsCancer Genetics up 16% on collaborating with Cellaria for precision medicine tools
seekingalpha.com - October 8 at 4:51 PM
Global Genetic Testing Market to Witness a CAGR of 12.2% during 2018-2024Global Genetic Testing Market to Witness a CAGR of 12.2% during 2018-2024
globenewswire.com - October 8 at 8:11 AM
Cancer Genetics and Cellaria Partner on Precision Medicine ToolsCancer Genetics and Cellaria Partner on Precision Medicine Tools
finance.yahoo.com - October 8 at 8:11 AM
Robbins Arroyo LLP: Cancer Genetics, Inc. (CGIX) Sued by Shareholders in Recently Filed Class ActionRobbins Arroyo LLP: Cancer Genetics, Inc. (CGIX) Sued by Shareholders in Recently Filed Class Action
finance.yahoo.com - September 29 at 8:09 AM
Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical TrialsCancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
finance.yahoo.com - September 20 at 4:57 PM
Cancer Genetics and NovellusDx Sign Definitive Agreement to MergeCancer Genetics and NovellusDx Sign Definitive Agreement to Merge
finance.yahoo.com - September 18 at 5:01 PM
Chardan Advises NovellusDX in Cross-Border Biotech MergerChardan Advises NovellusDX in Cross-Border Biotech Merger
finance.yahoo.com - September 18 at 5:01 PM
Four years after buying Morrisville firm, this out-of-town CEO wants to bolster NC opsFour years after buying Morrisville firm, this out-of-town CEO wants to bolster NC ops
finance.yahoo.com - August 17 at 5:40 PM
Cancer Genetics Q2 revenues up 6%; shares up 4% premarketCancer Genetics Q2 revenues up 6%; shares up 4% premarket
seekingalpha.com - August 15 at 8:15 AM
Edited Transcript of CGIX earnings conference call or presentation 14-Aug-18 12:30pm GMTEdited Transcript of CGIX earnings conference call or presentation 14-Aug-18 12:30pm GMT
finance.yahoo.com - August 15 at 8:15 AM
Cancer Genetics, Inc. (CGIX) CEO John Roberts on Q2 2018 Results - Earnings Call TranscriptCancer Genetics, Inc. (CGIX) CEO John Roberts on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 5:41 PM
Cancer Genetics beats by $0.03, misses on revenueCancer Genetics beats by $0.03, misses on revenue
seekingalpha.com - August 14 at 8:13 AM
Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business UpdatesCancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
finance.yahoo.com - August 14 at 8:13 AM
Cancer Genetics: 2Q Earnings SnapshotCancer Genetics: 2Q Earnings Snapshot
finance.yahoo.com - August 14 at 8:13 AM
IBM Bet Billions That Watson Could Improve Cancer Treatment. It Hasnt Worked.IBM Bet Billions That Watson Could Improve Cancer Treatment. It Hasn't Worked.
www.wsj.com - August 11 at 8:10 AM
Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
finance.yahoo.com - August 7 at 5:32 PM
Why pharma giant GSK just made a $300 million bet on 23andMes approach to finding new medicinesWhy pharma giant GSK just made a $300 million bet on 23andMe's approach to finding new medicines
www.businessinsider.com - July 26 at 8:12 AM
The CEO of Roche Pharmaceuticals explains why the company became a deal-machine in 2018The CEO of Roche Pharmaceuticals explains why the company became a deal-machine in 2018
www.businessinsider.com - July 26 at 8:12 AM
Cancer Genetics Closes $2.625 million Convertible Note FinancingCancer Genetics Closes $2.625 million Convertible Note Financing
finance.yahoo.com - July 18 at 4:54 PM
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial OfficerCancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
finance.yahoo.com - June 12 at 8:14 AM
Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against ...Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against ...
www.businesswire.com - June 6 at 5:32 PM
3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm3-Day Deadline Alert: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - June 2 at 8:16 AM
Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Cancer Genetics, Inc. (CGIX) and Encourages Investors to Contact the Firm Before June 4thBragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Cancer Genetics, Inc. (CGIX) and Encourages Investors to Contact the Firm Before June 4th
finance.yahoo.com - June 1 at 5:53 PM
CANCER GENETICS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in Cancer Genetics, Inc. to Contact the FirmCANCER GENETICS LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in Cancer Genetics, Inc. to Contact the Firm
finance.yahoo.com - June 1 at 5:53 PM
MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmMONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - May 31 at 5:33 PM
Safirstein Metcalf LLP Reminds Investors That A Class Action Has Been Filed Against Cancer Genetics, Inc. – CGIXSafirstein Metcalf LLP Reminds Investors That A Class Action Has Been Filed Against Cancer Genetics, Inc. – CGIX
feeds.benzinga.com - May 30 at 9:33 PM
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Cancer Genetics, Inc. (CGIX) and Lead Plaintiff Deadline - June 4, 2018
finance.yahoo.com - May 30 at 5:23 PM
This page was last updated on 1/20/2019 by MarketBeat.com Staff

Featured Article: Mutual Funds

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel